NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment
Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The newly designed contraceptive ring, Nuvaring has a lower total steroid dose, and
medications are delivered locally. It has been proven to be as safe and effective as the
combined OCP in ovarian suppression and preventing ovulation with fewer side effects due to
minimal systemic absorption. Following a single vaginal insertion, steroid concentrations
remain stable for up to 4 weeks. It is hypothesized that Nuvaring may, therefore lead to
better compliance, tolerability and acceptance by patients requiring ovarian suppression
prior to COH for IVF.